Daré Bioscience

Daré Bioscience

Daré Bioscience is a clinical-stage biopharmaceutical company offering products for women’s reproductive health.

Would it be accurate and relevant to link the text highlighted below to the topic Cerulean PharmaCerulean Pharma?

Dare Bioscience acquired Cerulean Pharma, a nanotechnology-based therapeutics company in 2017. In 2018 Dare Bioscience entered a merger with Pear Tree Pharmaceuticals that includes securing rights to PT-101, a vaginal formulation of tamoxifen as a treatment for vulvar and vaginal atrophy in hormone-receptor-positive breast cancer patients. 

This text snippet is from the topic Daré BioscienceDaré Bioscience